[CTXR] YoY Quarter Result on 30-Sep-2022 [#Q4]

Stock
[CTXR] Citius Pharmaceuticals, Inc.
Announcement Date
22-Dec-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q4]
Profit Trend
QoQ- 9.31%
YoY- -61.08%
Quarter Report
CTXR's Result
CTXR's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -9,800 -7,415 -4,961 -4,121 -3,650 -2,847 -3,043 21.51%
Tax 144 576 167 24 12 822 784 -24.59%
NP -9,944 -7,991 -4,961 -4,121 -3,650 -2,847 -3,043 21.80%
Tax Rate - - - - - - - -
Total Cost 9,944 7,991 4,961 4,121 3,650 2,847 3,043 21.80%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.06 -0.05 -0.03 -0.11 -0.18 -0.27 -0.56 -31.07%
EPS Diluted -0.06 -0.05 -0.03 -0.11 -0.18 -0.27 -0.56 -31.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.